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approved therapy for use in humans does not currently exist,
and viral pathogenesis is incompletely understood. In mice,
WNV induces systemic infection and then crosses the blood-
brain barrier, leading to encephalitis and death (Wang et al.,
2001, 2004). Induction of type-1 interferons (IFNs) (Anderson
and Rahal, 2002; Brinton, 2001; Gilfoy and Mason, 2007) and
humoral immunity (Diamond et al., 2003a, 2003b) provide
front-line defense against WNV pathogenesis, and cellular
immunity, including gd T cells (Wang et al., 2003a), CD4+ (Kul-
karni et al., 1991; Sitati and Diamond, 2006), and CD8+ (Shrestha
and Diamond, 2004, 2007; Shrestha et al., 2006; Sitati et al.,
2007; Wang et al., 2003b) ab T cells participate in host recovery
from WNV infection.
Toll-like receptors (TLRs) are a set of phylogenetically
conserved, germline-encoded molecules that play an essential
role in initiating innate immunity. Mammalian TLRs consist of
11–12 members that function as pattern recognition receptors
(PRRs) to sense pathogen-associated molecular patterns
(PAMPs) (Qureshi and Medzhitov, 2003; Yamamoto et al.,
2004). A large growing body of evidence implicates TLR recogni-
tion of a diverse set of pathogens, including bacteria (by TLR2,
TLR4, TLR6, and TLR9), flagellated protozoans (by TLR5), and
pathogenic fungi (by TLR2, TLR4, and TLR6) (Roeder et al.,
2004; Yamamoto et al., 2004). TLR2 and TLR4 recognize viral
proteins (Bieback et al., 2002; Kurt-Jones et al., 2000; Rassa
et al., 2002), and our data demonstrate that TLR3 mediates host
recognition of viral components (including double-stranded
RNA [dsRNA] and the dsRNA analog poly(I:C)) and intact virus
including Lang reovirus andWNV (Alexopoulou et al., 2001; Edel-
mann et al., 2004; Town et al., 2006; Wang et al., 2004). Further,
TLR7 and TLR8 are implicated in MyD88-dependent recognition
of ssRNA and ssRNA-producing viruses including vesicular
stomatitis virus, influenzavirus, humanparechoviris 1, andhuman
immunodeficiency virus (Diebold et al., 2004; Heil et al., 2004;
Lund et al., 2004; Schlaepfer et al., 2006; Triantafilou et al., 2005).SUMMARY
West Nile virus (WNV), amosquito-transmitted single-
stranded RNA (ssRNA) flavivirus, causes human
disease of variable severity. We investigated Toll-like
receptor 7-deficient (Tlr7/) and myeloid differentia-
tion factor 88-deficient (Myd88/) mice, which both
have defective recognition of ssRNA, and found
increased viremia and susceptibility to lethal WNV
infection. Despite increased tissue concentrations of
most innate cytokines, CD45+ leukocytes and
CD11b+macrophages failed tohometoWNV-infected
cells and infiltrate into target organs of Tlr7/ mice.
Tlr7/ mice and macrophages had reduced inter-
leukin-12 (IL-12) and IL-23 responsesafterWNV infec-
tion, and mice deficient in IL-12 p40 and IL-23 p40
(Il12b/) or IL-23 p19 (Il23a/), but not IL-12 p35
(Il12a/), responded similarly to Tlr7/ mice, with
increased susceptibility to lethal WNV encephalitis.
Collectively, these results demonstrate that TLR7
andIL-23-dependentWNVresponses representavital
host defense mechanism that operates by affecting
immune cell homing to infected target cells.
INTRODUCTION
West Nile virus (WNV) is a mosquito-transmitted single-stranded
RNA (ssRNA) virus that has emerged as themost common cause
of epidemic viral encephalitis in North America and has recently
become a worldwide public health concern (Campbell et al.,
2002; Debiasi and Tyler, 2006; Gould and Fikrig, 2004; Gubler,
2007). Although infection in humans is typically asymptomatic,
the elderly and immunocompromised are particularly at risk for
life-threatening neurological disease, including meningitis and
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still unclear. Because WNV is a positive ssRNA virus and may
therefore be detected by host TLR7 (Lund et al., 2004), we
sought to elucidate the role of TLR7 in controlling viral infection.
RESULTS
Tlr7/ and Myd88/ Mice Are More Susceptible
to Lethal WNV Infection
We used the mouse model of WNV encephalitis to examine the
role of TLR7 and MyD88 in viral recognition in vivo. Mice were
challengedwith 23 103 plaque-forming units (p.f.u.) of WNV cor-
responding to a dose at which approximately 50% of wild-type
(C57BL/6J) animals survive (LD50) and were monitored twice
daily for mortality. TLR7-deficient (Tlr7/) mice were signifi-
cantly more susceptible (9% survival) to lethal WNV infection
than were wild-type control mice (50% survival, p < 0.05; Fig-
ure 1). The adaptor molecule MyD88 is required for TLR7
signaling (Diebold et al., 2004; Hemmi et al., 2002; Lund et al.,
2004), and our data indicated a similar pattern of survival results
after WNV infection of MyD88-deficient (Myd88/) mice (15%
survival) compared to wild-type controls (p < 0.05; Figure 1).
TLR9 recognizes bacterial DNA containing unmethylated CpG
motifs (Hemmi et al., 2000) and, like TLR7, requires MyD88 for
signaling (Bauer et al., 2001; Hemmi et al., 2003). Furthermore,
it has recently been suggested that TLR9 might cooperate with
TLR7 in recognizing viral nucleic acid associated with murine
cytomegalovirus (Zucchini et al., 2008). However, our results
suggested that increased susceptibility of Tlr7/ mice to WNV
infection was specific, because TLR9-deficient (Tlr9/) mice
infected with WNV at LD50 (43% survival) were not significantly
different from controls (50% survival, p > 0.10; Figure 1).
Viral Load and Cytokines in Tlr7/ and Myd88/ Mice
after WNV Infection
We next examined viral load in the brain as well as systemically.
WNVwasdetected at high amounts in the spleen, liver, andblood
at days 2–3 postinfection (p.i.) and in the brain at day 6 p.i. (Wang
et al., 2004). Quantitative real-time polymerase chain reaction
(Q-PCR) measuring WNV envelope gene (WNVE) revealed
approximate 3-fold increased RNA abundance compared to
control mice in Tlr7/ mice (p < 0.05; Figure 2A) andMyd88/
mice (p < 0.05; Figure 2B) in blood at days 2–3 p.i. There was
also a modest (2-fold) but significant (p < 0.05) increase in
Myd88/ splenic WNVE RNA expression (Figure 2B) at day
3 p.i., which did not reach significance in Tlr7/ mice at day 3
(data not shown) but was significantly higher at day 6 p.i. (p <
0.01; Figure 2A). Strikingly,WNVERNAexpressionwasmarkedly
(8-fold) elevated in Tlr7/ brains at day 6 p.i. (p < 0.05; Figure 2A)
and was also significantly (3-fold) increased in Myd88/ brains
at day 6 p.i. (p < 0.05; Figure 2B).
Furthermore, infectious viral plaque formation assay was
carried out on Tlr7/ and control brains at day 6 p.i. with WNV
(LD50). Consistent withWNVEQ-PCR results, therewas a striking
increase in infectious virus recovered from Tlr7/ brains (n = 4;
1.333 107 pfu/g of brain ± 0.93 107 SEM) versus wild-type
brains (n = 5; 0.043 107 pfu/g of brain ± 0.033 107 SEM) that
trended toward statistically significant (p = 0.07). Additionally,
cytokine abundance was measured in blood and brain. Surpris-ingly, RNA expression of interferon-a (IFN-a), IFN-b, interleukin
(IL)-1b, IL-6, and tumor necrosis factor-a (TNF-a) were all signif-
icantly (*p < 0.05, **p < 0.01, ***p < 0.001) increased in blood from
WNV-infected Tlr7/ mice versus controls at day 3 p.i.
(Figure 2C).
Despite a generalized increase in systemic innate cytokine
RNAs after WNV infection of Tlr7/ mice, IL-12 p40 (the shared
cytokine chain with IL-23) RNA (Il12b) was significantly (p < 0.05)
reduced in blood samples from Tlr7/ mice versus controls
(Figure 2C), anda similar pattern of resultswasnoted for secreted
heterodimeric IL-23 protein in Myd88/ mice compared with
controls early after infection (Supplemental Experimental Proce-
dures available online) (p < 0.05; Figure 2D). Also, in concert with
reduced IL-12 p40 RNA in blood from Tlr7/ mice versus
controls, there was significant (p < 0.05) reduction in IL-12 p40
protein concentrations in blood plasma (Figure 2D). Quantifica-
tion of IL-12 p35, IL-12 p40, and IL-23 p19 RNAs in brains of
Tlr7/ mice versus controls at day 6 p.i. disclosed significant
(*p < 0.05, **p < 0.01) reductions in IL-12 p35 and IL-23 p19
RNAs in Tlr7/ mice (Figure 2E).
Immune Cell Homing to WNV-Infected Cells In Vivo
depends on TLR7 and MyD88
Next, we performed immunofluorescence analysis of WNV
antigen and CD11b (microglial and macrophage marker) or
CD45 (leukocyte marker) in brains of Tlr7/ versus control mice
at day 6 p.i. Our focus was on the olfactory bulb, because this
brain region is most sensitive to WNV infection and brain inflam-
mation (Wang et al., 2004). Consistent withWNVEQ-PCR, these
analyses revealed increased WNV antigen immunoreactivity in
brains of infected Tlr7/ mice compared with infected wild-
type animals (Figure 3A). Similar results were obtained in other
brain regions, including cerebral cortex, brainstem, cerebellum,
and striatum (data not shown). In wild-type mice, CD11b+ micro-
glia andmacrophages andCD45+ leukocyteswere found in close
Figure 1. Increased Susceptibility of Tlr7/ andMyd88/Mice, but
Not Tlr9/ Mice, after West Nile Virus Challenge
Wild-type mice (n = 24), Tlr7/ mice (n = 22), Myd88/ mice (n = 13), and
Tlr9/ mice (n = 14) were i.p. infected with WNV (LD50) and monitored twice
daily for 21 days for mortality. Data shown are represented as time after infec-
tion (days) on the x axis and percent survival (%) on the y axis. Kaplan-Meier
survival analysis revealed significant differences between wild-type and
Tlr7/ or Myd88/ mice, but not between wild-type and Tlr9/ mice. Data
shown are pooled from 2–4 independent experiments.Immunity 30, 242–253, February 20, 2009 ª2009 Elsevier Inc. 243
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However, despite increased WNV burden, CD11b+ and CD45+
immune cells failed to home to infected brain cells in Tlr7/
mice, although they were detected in these mice at a distance
from WNV-infected brain cells (Figure 3A). As expected, unin-
fected (control) brain sections from wild-type or Tlr7/ mice
did not display signal for WNV antigen, CD45, or CD11b (Fig-
ure 3A). A more severe phenotype was observed in infected
Myd88/ brains, where CD45+ cells were nearly absent (Fig-
ure S1A), despite increased WNV burden (Figure S1B).
To determinewhether impaired immune cell homing in infected
Tlr7/ mice was specific to the brain, we also analyzed livers
(another target organ of WNV infection) (Venter et al., 2005) from
wild-type versus Tlr7/ mice at day 3 p.i.. In wild-type mice,
confocal microscopy revealed numerous CD45+ leukocytes in
close vicinity of infected hepatocytes. However, a different
pattern of results was evident in Tlr7/mice. Similar to observa-
tions in brain, CD45+ cells were present, but were often found at
a distance from WNV infected hepatocytes (Figure 3B). This
phenotypewasevenmorestrikingwhenconsidering that infected
Tlr7/mouse livers hadnearly 6-fold higher abundanceofWNVE
RNA copies compared with wild-type controls (p < 0.01;
Figure 3C). Furthermore, this effect was associated with signifi-
cantly (p < 0.05) reduced IL-23 p19 RNA in Tlr7/ versus
Figure 2. Tlr7- and Myd88-Dependent Viral
Load and Innate Immune Cytokine Re-
sponses after West Nile Virus Challenge
Wild-type, Tlr7/, or Myd88/ mice were i.p.
challenged with West Nile virus (LD50).
(A) Quantitative real-time PCR (Q-PCR; mean unit-
less ratio + 1 SEM) was performed for WNVE on
day (D) 3 postinfection peripheral blood, D6
perfused brain, or D6 perfused spleen samples
from wild-type versus Tlr7/ mice.
(B) Q-PCR results (mean unitless ratio + 1 SEM) for
WNVE on D3 peripheral blood, D3 spleen, or D6
perfused brain samples from wild-type versus
Myd88/ mice.
(C) Q-PCR results (mean unitless ratio + 1 SEM) for
blood innate immune cytokines in wild-type and
Tlr7/ mice on D3 after infection.
(D) ELISA results (pg/mL; mean + 1 SEM) for IL-23
(left bars) or IL-12 p40 (right bars) in blood samples
from wild-type, Myd88/, or Tlr7/ mice on D2
(Myd88/ mouse experiment) or D3 (Tlr7/
mouse experiment) after infection.
(E) Q-PCR results (mean unitless ratio + 1 SEM) for
brain innate immune cytokines in wild-type and
Tlr7/ mice on D6 after infection.
Data are pooled results from 2–4 similar indepen-
dent experiments, with at least n = 3 (and up to
n = 22) per group for each experiment. ***p <
0.001, **p < 0.01, and *p < 0.05 compared to
wild-type mice.
wild-type mouse livers (Figure 3D). To
determine whether this effect was owed
to a generalized defect in Tlr7/ immune
cells, macrophages were recovered from
the peritoneal cavity at 4 days after thio-
glycollate injection and enumerated.
There was a modest nonsignificant trend for more cells in
the Tlr7/ mice (n = 4 mice per group, means ± SD for wild-
type versus Tlr7/ mice: 7.163 106 ± 1.943 106 versus
9.143 106 ± 1.613 106; p = 0.17), indicating that macrophage
recruitment, locomotion, andhomingwere intact in theseanimals.
When taken together, these data suggested that TLR7 mediated
immune cell homing to WNV-infected target cells in vivo and
that this effect was associated with IL-12 and IL-23 responses.
Recognition ofWNVTriggers TLR7 and IL-23-Dependent
Macrophage Chemotaxis In Vitro
To determine whether reduced immune cell homing to WNV-
infected cells in Tlr7/ mice could be recapitulated in vitro, we
established a transwell chemotaxis assay. Because CD11b+
macrophage cell homing to infected target cells was inhibited
in Tlr7/ mice, peripheral macrophages were elicited from
Tlr7/ and wild-type mice for in vitro chemotaxis analyses.
Lower chambers of transwell plates (containing a glass cover-
slip) were loaded with a dose range of the TLR7 small molecule
agonist loxoribine (loxO), supernatants from WNV-infected
neuroblastoma-2a (N2a) lysates, or macrophage chemoattrac-
tant protein-1 (MCP-1, as a positive control), and 13 105 macro-
phages were placed in the upper chamber. After 6 hr, lower-
chamber glass coverslips were recovered and immunolabeled244 Immunity 30, 242–253, February 20, 2009 ª2009 Elsevier Inc.
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phage migration was increased in response to loxO, infected
N2a lysate supernatants, and MCP-1. Yet, although Tlr7/
macrophages increased migration toward MCP-1, indicating
an intact chemotactic response, they were refractive to loxO or
infected N2a lysate supernatants (Figure 4A). Quantitation
revealed significantly (*p < 0.05, **p < 0.01, ***p < 0.001) reduced
chemotaxis of Tlr7/ macrophages toward loxO (at 50 or
100 mM) or infectedN2a lysate supernatants (multiplicity of infec-
tion [MOI] = 0.5, from undiluted to 1:50), but not toward MCP-1
(Figure 4B). We also infected N2a cells with MOI = 1 of WNV
and prepared cell lysate supernatants and noted similar effects
with this material on Tlr7/ versus wild-type macrophages
transwell migration (data not shown).
Figure 3. In Vivo Leukocyte Homing toWest
Nile-Infected Cells Is Tlr7 Dependent
Wild-type (WT) or Tlr7/ mice were i.p. chal-
lenged with WNV (LD50). Uninfected WT and
Tlr7/ mice were euthanized and processed
side-by-side as negative controls.
(A) Perfused brains were isolated on day 6 postin-
fection, and WNV antigen (green signal) and CD45
(leukocyte common antigen, red signal) or CD11b
(macrophage and microglia marker, red signal)
were detected by immunofluorescence with a
Zeiss ApoTome-equipped epifluorescence micro-
scope (original magnification 633).
(B) Perfused livers were isolated on day 3 postin-
fection, and WNV antigen (green signal) and
CD45 (red signal) were imaged with a Zeiss Apo-
Tome-equipped epifluorescence microscope
(original magnification 203). DAPI (blue signal)
was used as a nuclear counterstain, and represen-
tative images are shown. Numbers of CD45+ or
CD11b+ cells per image colocalized with WNV
antigen+ areas (first number) and total CD45+ or
CD11b+ cells per image (second number) are
shown in the bottom right in (A) and (B).
(C) Quantitative PCR for WNVE in wild-type or
Tlr7/ livers at day 3 p.i. Graph shows means +
1 SEM.
(D)QuantitativePCR for Il23a inwild-typeorTlr7/
livers at day 3 p.i. Graph shows means + 1 SEM.
Similar results were observed in 2–4 independent
experiments with at least n = 4 per group for each
experiment. **p < 0.01 and *p < 0.05 compared to
wild-type mice.
Next, we determined whether the inhi-
bition of migration of Tlr7/ macro-
phages in response to WNV infection
was associated with reduced IL-12 and
IL-23 amounts. Tlr7/ and wild-type
macrophages were infected with WNV
(MOI = 1) and assayed for IL-12 p40
RNA and IL-23 p19 protein by Q-PCR
and immunoblot, respectively. Infected
Tlr7/ macrophages produced signifi-
cantly (p < 0.01) less IL-12 p40 RNA
compared with wild-type cells, and
WNV-induced IL-23 p19 protein was also
clearly reduced in infected Tlr7/ macrophages (Figure 5A).
Additionally, Tlr7/ macrophages were completely nonrespon-
sive to a dose-range of loxO when measuring IL-12 p40 or
TNF-a, which further suggested that the above effect was
TLR7 dependent (Figure S2).
In our model, we proposed that brain-resident macrophages
(microglia) initially produced IL-12 and IL-23 upon TLR7 recogni-
tion of brain-penetrating WNV and that infiltrating macrophages
and other leukocytes would then migrate in response to this
signal. If this were the case, then one might expect reduced
IL-12 receptor (R) and IL-23Rexpression to underlie hyporespon-
siveness of Tlr7/ macrophages to WNV-induced chemotaxis.
In an effort to address this possibility, Tlr7/ or wild-typemacro-
phages were challenged with a dose-range of loxO, and proteinImmunity 30, 242–253, February 20, 2009 ª2009 Elsevier Inc. 245
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and IL-23 share the IL-12p40subunit (Cooper andKhader, 2007),
their receptors also formheterodimers sharing thecommonchain
IL-12Rb1 subunit (van de Vosse et al., 2003). Although IL-12Rb2
and IL-23R were not further inducible in Tlr7/ and wild-type
macrophages after loxO challenge, IL-12Rb1 was induced in
wild-type macrophages, but Tlr7/ macrophages were nonre-
sponsive (Figure 5B). It was next determinedwhetherWNV infec-
tion of wild-type versus Tlr7/ macrophages could produce
a similar effect. Similar to loxO challenge, WNV at MOI = 1 or 2
induced IL-12Rb1 expression in wild-type macrophages, but
this response was inhibited in Tlr7/ macrophages (Figure 5C).
Finally, we examined whether IL-23 or IL-12 could directly affect
TLR7-dependent macrophage chemotaxis in vitro by using our
transwell assay. Results showed that IL-23 dose dependently
(from 2.5 to 10 ng/mL) augmented chemotaxis of wild-type but
not Tlr7/ macrophages (Figure 5C). However, both wild-type
and Tlr7/ macrophages were refractive to IL-12 p70 chemo-
taxis (n = 3 transwells per group,means ± SD forwild-type versus
Tlr7/ macrophages for cells per high power field, 0 ng: 4
cells ± 1 cell versus 4.33 cells ± .58 cells; 2.5 ng: 4.67 cells ± .58
cells versus 5.33 cells ± .58 cells; 5.0 ng: 4.67 cells ± .58 cells
versus 5.33 cells ± .58 cells; 10 ng: 4.33 cells ± .58 cells versus
4.67 cells ± .58 cells). Thus, IL-23 (and not IL-12) was responsible
for TLR7-dependent macrophage chemotaxis in vitro.
Figure 4. Tlr7-Dependent Macrophage
Homing In Vitro
(A) Peritoneal thioglycollate-elicited macrophages
were prepared from wild-type or Tlr7/ mice and
placed in the upper chamber of transwell plates. In
the lower chamber, the TLR7 agonist loxoribine
(loxO, from 0 to 100 mM), supernatants from
WNV-infected N2a cell lysates (MOI = 0.5, diluted
from 1:1 to 1:50), or macrophage chemoattractant
protein-1 (MCP-1, 1000 mg/mL) was added for
6 hr. Glass coverslips placed in the lower chamber
were recovered for confocal microscopy for
CD11b (green signal). DAPI (blue signal) was
used as a nuclear counterstain (original magnifica-
tion 633), and representative images are shown.
(B) CD11b+ cells in high-power fields (original
magnification 633) were counted (n = 3 per condi-
tion), and data are presented as means + 1 SD.
Similar results were obtained in 3–4 independent
experiments. **p < 0.01 and *p < 0.05 compared
to wild-type macrophages.
To determine whether the effects we
observed in Tlr7/ macrophages might
be due to a compensatory Tlr response,
Tlr Q-PCR array was performed on
WNV-infected macrophages, and only
Tlr7 RNA was substantially altered after
infection in Tlr7/ macrophages (data
not shown). Further, Q-PCR arrays were
carried out for chemokines and chemo-
kine receptors, and cytokines and cyto-
kine receptors, to identify any additional
targets of TLR7 after WNV infection, but
there were no obvious alterations (data not shown). Finally,
supernatants from infected macrophages were assayed by
protein cytokine array and we did not observe obvious differ-
ences between wild-type and Tlr7/ macrophages (data not
shown). Thus, according to unbiased approaches, additional
TLR7-dependent targets of WNV were not identified in macro-
phages.
Immune Cell Homing to WNV-Infected Cells
Is TLR7-IL-23 Dependent In Vivo
Our data thus far suggested that recognition of WNV by TLR7
caused IL-23-dependent immune cell homing. To directly test
this hypothesis in vivo, wild-type, IL-12 p35-deficient (Il12a/),
IL-12 p40-deficient (Il12b/), or IL-23 p19-deficient (Il23a/)
mice were infected with WNV and we assessed infected brains
for presence of WNV and infiltrating leukocytes by confocal
microscopy on day 6 p.i.. Wild-type and Il12a/ mice demon-
strated CD11b+ macrophages and microglia (Figure 6) and
CD45+ leukocytes (Figure S3A) in close apposition to infected
brain cells. However, in both Il12b/ and Il23a/ mice,
CD11b+ macrophages and microglia (Figure 6) and CD45+
leukocytes (Figure S3A) were not clearly colocalized to foci of
WNV-infected cells. Further, Il23a/ mice had fewer infiltrating
CD11b+ macrophages and microglia (Figure 6) that were not
clearly associated with WNV-infected brain cells. Thus, proper246 Immunity 30, 242–253, February 20, 2009 ª2009 Elsevier Inc.
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cells required IL-23.
To better define and enumerate brain immune cells, wild-type,
Tlr7/, Myd88/, Il12a/, Il23a/, or Il12b/ mice were in-
fected with WNV (LD50) and brains were isolated on day 6 p.i..
We applied flow cytometry methodology to single-cell suspen-
sions of harvested brains to characterize numbers of brain-
infiltrating macrophages (based on CD45hiCD11b+ status;
Juedes and Ruddle, 2001; Town et al., 2008), brain-resident
microglia (by CD45intCD11b+F4/80 Ag+; Juedes and Ruddle,
2001; Town et al., 2008), and brain-infiltrating CD45hiCD4+ and
CD45hiCD8+ T cells in these mice. In concert with our confocal
microscopic analyses, brain-infiltrating macrophages were
reduced by 59% to as much as 98% when comparing wild-type
to Tlr7/, Myd88/, Il12b/, or Il23a/ mice, whereas
Il12a/mice appeared similar to wild-typeWNV-infected brains
(Figure 7). A generally similar pattern of results was evident when
considering CD4+ and CD8+ T cells, which were attenuated
between 55% and 89% when comparing wild-type to Tlr7/,
Myd88/, or Il12b/ mice, whereas Il12a/ or Il23a/ mice
appeared similar to wild-type WNV-infected brains (Figure 7).
However, a different pattern of results emergedwhenconsidering
brain-resident microglia, which did not obviously differ fromwild-
type WNV-infected brains except for an apparent 75% reduction
in Il12b/ mice (Figure 7). We also analyzed B cells by CD19
expression, but did not detect consistent differences between
these mouse genotypes (data not shown).
To determine whether impaired leukocyte homing to WNV-in-
fected brains was due to a general defect in leukocyte expansion
or differentiation, or cell death in the periphery, we analyzed
spleens from the same animals as above and did not detect
any differences between genotypes (data not shown). Interest-
ingly, similar effects are reported in other neuroinflammatory
conditions where peripheral leukocytes infiltrate into the central
nervous system (CNS) of (1) experimental autoimmune enceph-
alomyelitis-induced mice or (2) Alzheimer’s mouse models in the
absence of innate immune TGF-b signaling, but populations of
these cells in the periphery are essentially unaltered (Laouar
et al., 2008; Town et al., 2008). Taken together, these brain
flow cytometry results corroborated our confocal microscopic
analyses and strengthened our conclusion that brain infiltration
or homing of leukocytes (specifically, macrophages and
T cells) to WNV-infected CNS was dependent on TLR7-
MyD88-IL-23 signaling.
Finally, we determined whether survival after lethal WNV
encephalitis was dependent on IL-12, IL-23, or both. Thus, wild-
type, Il12a/, Il12b/, or Il23a/ mice were infected with WNV
(LD50) andmonitored twicedaily for survival.Basedonour findings
of IL-23-dependent immune cell homing to WNV-infected brain
cells, we hypothesized reduced survival in Il12b/ and Il23a/
but not Il12a/ mice after lethal WNV challenge. Results were
consistent with this hypothesis. Specifically, although Il12a/
mice did not differ from wild-type controls (42% survival for both
groups, p > 0.10; Figure S3B), both Il12b/ mice (27% survival
versus 53% for wild-type controls, p < 0.05; Figure S3B) and
Il23a/ mice (0% survival versus 25% for wild-type controls, p
<0.01; FigureS3B)weremore susceptible to lethalWNV infection.
Collectively, these results showed that survival after lethal WNV
challenge required intact IL-23 as opposed to IL-12 responses.DISCUSSION
Mammalian innate immune responses are a vital first line of
defense against invading pathogens. Notably, TLRs are indis-
pensable sensors of PAMPs and function to drive innate immune
responses that fine-tune adaptive immunity (Qureshi and Medz-
hitov, 2003; Yamamoto et al., 2004). It is known that TLR3 recog-
nizes dsRNA (Alexopoulou et al., 2001; Town et al., 2006). WNV
is a positive ssRNA flavivirus that produces dsRNA during its life
cycle, and Tlr3/ mice have reduced susceptibility to lethal
WNV encephalitis (Wang et al., 2004). This finding implicates
TLR3 as a host immune receptor that recognizes WNV dsRNA.
Furthermore, the virus uses TLR3 to promote infectivity of the
host by eliciting systemic TNF-a that increases permeability of
the blood-brain barrier. Yet, most WNV infections in humans
are asymptomatic (Campbell et al., 2002; Davis et al., 2006),
highlighting that host immune mechanisms must exist to
suppress WNV infection. In this report, we showed that Tlr7/
mice had increased susceptibility to lethal WNV encephalitis;
this finding pointed to TLR7 as the host’s first line of defense
against WNV infection, by recognizing ssRNA present immedi-
ately upon viral entry into the host—even before the first round
of replication. TLR7 is thought to exclusively rely on MyD88 as
an adaptor molecule, and, consistent with this notion, we found
thatMyd88/mice phenocopy Tlr7/mice on reduced survival
after lethal WNV infection.
We sought to understand the cellular mechanism responsible
for increased sensitivity of Tlr7/ and Myd88/ mice to lethal
WNV encephalitis. Interestingly, viral burden was increased
both systemically and in brains of Tlr7/ and Myd88/ mice,
suggesting that loss of these innate immune molecules caused
a failure of the host to control viral infectivity. Surprisingly,
Tlr7/ mice had increased systemic concentrations of most
innate proinflammatory cytokines after WNV challenge including
IFN-a, IFN-b, IL-1b, IL-6, and TNF-a, thought to be key media-
tors of host antiviral immunity (Anderson and Rahal, 2002; Brin-
ton, 2001; Gilfoy and Mason, 2007). This paradoxical result is
most likely owing to other innate immune viral PRRs, such as
TLR3, RIG-I, and MDA-5, which would still be expected to oper-
ate in Tlr7/ mice upon WNV infection. Further, WNV infection
studies in Il6/ and TNF-soluble receptor type I-deficient
(Tnfsr1/) mice show that this reduced susceptibility is depen-
dent on TNF-a (but not IL-6) signaling through the type I receptor
(Tnfsr1), resulting in increased blood-brain-barrier permeability
and consequent enhanced entry of the virus into the CNS
(Wang et al., 2004). Importantly however, recent reports using
a different WNV strain show a protective role of TLR3 and Tnfsr1,
suggesting that host antiviral innate immunity may beWNV strain
specific (Daffis et al., 2008; Shrestha et al., 2008). Plasmacytoid
dendritic cells (pDCs) are thought to be the primary source of
IFN-a and IFN-b produced in response to viral infection via the
TLR7 signaling pathway (Cella et al., 1999; Hornung et al.,
2002). However, in response to WNV challenge, Tlr7/ mice
paradoxically produced more IFN-a and IFN-b than did wild-
type mice. Therefore, it seemed unlikely to us that dysfunction
of pDCs was the underlying cause of increased susceptibility
to WNV in Tlr7/ mice.
In contrast to the increased amounts of IFN-a, IFN-b, IL-1b,
IL-6, and TNF-a, there was reduction of systemic IL-12 p40 andImmunity 30, 242–253, February 20, 2009 ª2009 Elsevier Inc. 247
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Toll-like Receptor 7 and West Nile EncephalitisFigure 5. Tlr7 and IL-23 Signaling-Dependent Macrophage Responses
(A) Peritoneal thioglycollate-elicited macrophages were prepared from wild-type (WT) or Tlr7/ mice (key applies to [A] and [C]) and infected with WNV at
MOI = 1. 24 hr thereafter, cell lysates were prepared for Il12b Q-PCR analysis (left, unitless ratio + 1 SEM) or immunoblot for IL-23 p19 and actin as a loading
control (middle). Densitometry (ratio of IL-23 p19 to actin signal) is shown in right panel.248 Immunity 30, 242–253, February 20, 2009 ª2009 Elsevier Inc.
Immunity
Toll-like Receptor 7 and West Nile Encephalitisbrain IL-12 p35 and IL-23 p19 after lethalWNV infection of Tlr7/
mice. Additionally,Myd88/ mice had reduced systemic abun-
dance of IL-23. Further, homing of leukocytes and microglia and
macrophages to WNV-infected cells was impaired in Tlr7/ and
Myd88/ mice. This effect could be recapitulated in vitro,
because we found that whereas wild-type macrophages
migrated toward either the TLR7 agonist loxO or infected super-
natants fromWNV-infected neuron-like cells,migration of Tlr7/
macrophages was significantly inhibited. However, it should be
noted that thioglycollate-elicited peritoneal macrophages do
not necessarily reflect the behavior of monocytes or tissue
macrophages such as microglia and Kupffer cells. We went on
to hypothesize that TLR7 recognition of WNV promotes IL-12-
IL-23-dependent immune cell homing to infected target cells.
Interestingly, TLR7 cooperates with heat-shock protein 70 to
promote macrophage phagocytosis (Wang et al., 2006), raising
the possibility that TLR7may promote both macrophage homing
to and clearance of WNV-infected cells.
The IL-12-IL-23 axis has recently emerged as a key immuno-
modulatory pathway. Interestingly, it is postulated that ‘‘tipping
the balance’’ between IL-12 and IL-23 controls the outcome of
Figure 6. Macrophage Homing to West Nile
Virus Is IL-23 Signaling Dependent
Wild-type (n = 6), Il12a/ (n = 4), Il12b/ (n = 4),
and Il23a/ (n = 3) mice were infected with West
Nile virus (LD50). Brains were isolated on day 6
after infection and immunostained for confocal
microscopy with antibodies against CD11b (green
signal) and WNV antigen (red signal) to reveal
microglia and infiltrating macrophages in WNV-
infected brain regions. TOPRO3 was used as
a nuclear counterstain (blue signal) and merged
images are shown to the right. Numbers of
CD11b+ cells per image colocalized with WNV
antigen+ areas (first number) and total CD11b+
cells per image (second number) are shown in
the bottom right. Similar results were obtained in
2–4 independent experiments.
inflammatory responses, with the IL-23
arm of the scale leading to production of
IL-17 via T helper 17 (Th17) cells (Goriely
et al., 2008). IL-17 plays a ‘‘certain but
subdominant role’’ in IL-23-mediated
resistance to vaccinia virus (Kohyama
et al., 2007), demonstrating that IL-17
(likely induced by IL-23 produced by
innate immune cells) may link innate
immune TLR-IL-23 signaling with adap-
tive immune Th17 cells. In support of
this, it was recently demonstrated that
IL-17 is secreted into supernatants from human peripheral blood
mononuclear cells treated with TLR7 and TLR8 agonists (Kattah
et al., 2008). Based on results reported here linking TLR7 and IL-
23 signaling, future studies are warranted to evaluate the puta-
tive role of IL-17 in WNV encephalitis.
Because IL-12 and IL-23 share the p40 subunit and both utilize
the common IL-12Rb1 chain for signaling, it was initially difficult
to tease apart effects from these two cytokines. For example,
although it was once thought that IL-12 mediated the inflamma-
tory, autoaggressive response in experimental autoimmune
encephalomyelitis, it was later shown in a seminal report that
IL-23 was the responsible cytokine (Cua et al., 2003). TLR
ligands differentially promote IL-12 and IL-23 production in
innate immune cells. Specifically, TLR2 recognition of Gram-
positive bacteria and fungi by dendritic cells leads to induction
of p40 and p19 subunits (but not p35), whereas TLR3 stimulation
by viruses or TLR4 engagement by Gram-negative bacteria
induces all three subunits (Bekeredjian-Ding et al., 2006; Gautier
et al., 2005; Goriely et al., 2006; Napolitani et al., 2005; Re and
Strominger, 2001). We found IL-12 p40 RNA and IL-23 p19
protein induction in wild-type macrophages after WNV infection,(B) Macrophages were stimulated with the TLR7 ligand loxoribine (loxO, from 0 to 250 mM as indicated) for 24 hr, and cell lysates were immunoblotted for
IL-12Rb1, IL-12Rb2, IL-23R, or actin (left). Densitometry (ratio of IL-12Rb1 to actin signal) is shown in right panel (n = 3 for each condition).
(C) Macrophages (left) were infected with WNV (from 1.0 to 2.0 MOI), and cell lysates were harvested 24 hr later for immunoblot analysis of IL-12Rb1, IL-12Rb2,
IL-23R, or actin. Densitometry (ratio of target signal to actin) is shown in graphs below each immunoblot.Macrophages (right) were placed in the upper chamber of
transwell plates, and IL-23 (from 0 to 10 ng/mL) was placed in the lower chamber. 6 hr later, CD11b+ cells in high-power fields were counted on glass coverslips in
the lower chamber by confocal microscopy (n = 3 per condition). **p < 0.01 and *p < 0.05 compared to wild-type macrophages at the same dose. Means ± 1SD
are shown in (B) and (C). Similar results were observed in 2–4 independent experiments.Immunity 30, 242–253, February 20, 2009 ª2009 Elsevier Inc. 249
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Toll-like Receptor 7 and West Nile EncephalitisFigure 7. Characterization of Brain Immune
Cells in Wild-Type, Tlr7/, Myd88/,
Il12/, and Il23/ Mice after West Nile
Virus Infection
Brain flow cytometry results are shown from 2–3
independent experiments on day 6 post-WNV
infection (LD50; n = 1–5 mice per genotype and
numbers represent percentages ± SD for the indi-
cated gates). The 37:70% Percoll interface was
collected and stained for CD45, CD4, CD8,
CD11b, and F4/80 antigen as indicated in (A) (right,
applies for all panels). A minimum of 100,000
events were collected for flow cytometry analysis,
and dot plots show side scatter (SSC) on the x axis
and CD45 log fluorescence intensity on the y axis.
Numbers represent percentages of positive cells
within gated regions.
(A) Brain flow cytometry results are shown from
wild-type vs. Tlr7/ mice.
(B) Brain flow cytometry data are shown for wild-
type compared to Myd88/ or Il12a/ mice.
(C) Brain flow cytometry data are shown for wild-
type compared to Il23a/ or Il12b/ mice.250 Immunity 30, 242–253, February 20, 2009 ª2009 Elsevier Inc.
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Additionally, the IL-12 and IL-23 common receptor chain, IL-
12Rb1, was induced in a TLR7-dependent fashion after loxO
challenge or WNV infection. It was noteworthy that IL-12Rb2
(which pairs with IL-12Rb1 to promote IL-12 signaling) was
constitutively reduced in Tlr7/ macrophages, suggesting
a compensatory mechanism whereby these cells were ‘‘biased’’
in favor of IL-23 as opposed to IL-12 responses.
To further determine whether TLR7-dependent immune
responses were dependent on IL-12 or IL-23 (or both) pathways,
we (1) evaluated wild-type versus Tlr7/ macrophage homing
both in vitro in response to IL-12 or IL-23 and in vivo in WNV-in-
fected wild-type versus Il12a/, Il12b/, or Il23a/ mice, and
(2) performed survival analysis after WNV infection of wild-type
versus Il12a/, Il12b/, or Il23a/ mice. Exogenous addition
of IL-23 (but not IL-12) was able to promote chemotaxis of
wild-type macrophages, whereas Tlr7/ macrophages were
refractive to stimulation. Consistently, WNV infection led to
impaired immune cell homing to infected brain cells in Il12b/
and Il23a/ mice, but not in Il12a/ mice. If IL-23-dependent
immune cell homing to infected target cells were a mitigating
factor against lethal WNV encephalitis, one would expect
reduced survival after challenge with a lethal dose of WNV in
Il12b/ and Il23a/mice, but not in Il12a/ animals. A pattern
of results consistent with this hypothesis was observed. Interest-
ingly, a previous report has shown that the chemokine receptor
CCR5 is required for leukocyte trafficking to the brain andmitiga-
tion of lethal WNV encephalitis (Glass et al., 2005), further
highlighting the role of immune cell infiltration and homing as
an essential host defense mechanism.
Our results suggest amodel of host-WNVpathogen interaction
that requires intact TLR7 and IL-23 signaling to promote effective
viral clearance. Specifically, we postulate in this model that resi-
dent tissue macrophages in WNV target organs such as Kupffer
cells in liver and microglia in brain sense tissue-invading WNV
bywayof TLR7 recognition of viral ssRNA. These residentmacro-
phages then secrete IL-23, which promotes infiltration and
homing of peripheral immune cells including blood-bornemacro-
phages ormonocytes, which in turn upregulate IL-12Rb1 in order
to receive the IL-23 signal. Once infiltrated into WNV target
organs, these peripheral immune cells can then affect neutraliza-
tion and clearance of the virus by both TLR7-IL-23-dependent
and -independent mechanisms. The importance of TLR7 in
promoting immune cell activation is further underscored by
inflammatory responses and autoimmunity in TLR7-overex-
pressing mice (Deane et al., 2007). Taken together, our results
show that TLR7 is a critical host sensor of WNV required for
IL-23-dependent immune cell homing to infected target cells
and suggest that pharmacotherapy aimed at promoting TLR7-
IL-23 signaling will be beneficial for treatment of WNV and
perhaps other encephalitides.
EXPERIMENTAL PROCEDURES
Mice
Tlr7/ (Lund et al., 2004),Myd88/ (Adachi et al., 1998), and Tlr9/ (Hemmi
et al., 2003)micewere bred to theC57BL/6 background bybackcrossing for 10
successive generations. Il12a/ (Mattner et al., 1996) and Il12b/ (Magram
et al., 1996) mice on a C57BL/6 background were obtained from Jackson
Laboratories. Il23a/mice (Cua et al., 2003) on amixed C57BL/63 129 back-ground were obtained from the Mutant Mouse Regional Resource Center
(MMRRC). We performed all experiments on 8- to 12-week-old mice, and
mouse groupswere rigorously age- and sex-matched for each infection exper-
iment. All experiments were performed with approval from the Yale Animal
Resources Center Institutional Animal Care and Use Committee.
Virus Infection
We inoculated mice intraperitoneally with 2000 plaque-forming units (p.f.u.)
(LD50) of WNV isolate 2741 in 100 ml of PBS with 5% gelatin as previously
described (Wang et al., 2004). Mice were observed for up to 21 days after
infection and we checked them twice daily for morbidity (including lethargy,
anorexia, and difficulty ambulating) and mortality.
Quantitative PCR
Ribonucleic acid was extracted from blood, spleen, liver, and brain tissue with
the RNeasy kit (QIAGEN). RNAwas used to synthesize complementary (c) DNA
with the ProSTAR First-strand RT-PCR kit (Stratagene). The flurogenic probes
and primers that we used have been described elsewhere (Wang et al., 2004).
Probes contained a 50 reporter, FAM, and a 30 quencher, TAMRA (Applied
Biosystems). The assay was performed on an iCycler (Bio-Rad). The thermal
cycling consisted of 95C for 3.5 min and 48 cycles of 95C for 30 s and
60C for 1 min. To normalize the samples, the same amount of cDNA was
used in the Actb Q-PCR. The ratio of the amount of amplified gene compared
with the amount of Actb cDNA represented the relative amounts in each
sample.
Immunofluorescence Imaging
Brains and livers were rapidly isolated, fixed in 4% paraformaldehyde (PFA)
overnight at 4C, and cryoprotected in a graded series of sucrose (10%,
20%, and 30%, each overnight at 4C). Spleens from infected mice sacrificed
day 3 postinfection were used as a positive control to ensure specificity of
WNV antibodies (data not shown). Para-median sagital sections were cut at
25 mm with a cryostat. Tissue sections were PAP pen (Zymed Laboratories)
applied and preblocked in serum-free protein block (Dakocytomation) for
30 min at ambient temperature. Sections were then reacted overnight at 4C
with various combinations of primary antibodies against CD11b (Serotec;
1:200), CD45 (Serotec, 1:200), or WNV antigen (from J.F. Anderson; 1:250).
After three rinses in PBS, sections were reacted with appropriate secondary
antibodies conjugated with Alexa Fluor 488, 594, or 647 for 1 hr at ambient
temperature. After three additional rinses in PBS, sections were then nuclear
counterstained with DAPI or TOPRO3 (Invitrogen) and mounted in fluores-
cence mounting medium (ProLong Gold). Images were acquired in indepen-
dent channels with a Zeiss ApoTome-equipped fluorescence microscope or
a Zeiss LSM510 META confocal microscope. Immune cells in brain and liver
and numbers of immune cells colocalized with WNV-infected target cells
were counted in a blind fashion with Zeiss Axiovision software.
Statistical Analysis
We calculated standard errors of the means (SEM) and standard deviations
(SD) and analyzed data by nonpaired Student’s t test for single mean compar-
isons or ANOVA and post-hoc testing for multiple comparisons of the means.
Survival curve comparisons were conducted with the log-rank test (equivalent
to the Mantel-Haenszel test, Prism software).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and three
figures and can be found with this article online at http://www.immunity.com/
supplemental/S1074-7613(09)00064-8.
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